Screener
Medtronic MDT Cardiovascular — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions) | Worldwide / Fiscal Year / 2026 | Worldwide / Fiscal Year / 2025 | Worldwide / Fiscal Year / 2024 |
|---|---|---|---|
| Cardiac Rhythm & Heart Failure | $7,504 | $6,392 | $5,995 |
| Structural Heart & Aortic | 3,817 | 3,554 | 3,358 |
| Coronary & Peripheral Vascular | 2,656 | 2,535 | 2,478 |
| Cardiovascular | 13,976 | 12,481 | 11,831 |
| Cranial & Spinal Technologies | 5,222 | 4,973 | 4,756 |
| Specialty Therapies | 2,997 | 2,940 | 2,905 |
| Neuromodulation | 2,068 | 1,932 | 1,746 |
| Neuroscience | 10,287 | 9,846 | 9,406 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's cardiovascular — net sales?
- Medtronic (MDT) reported cardiovascular — net sales of $3.8B in Q1 2026.
- How has Medtronic's cardiovascular — net sales changed year-over-year?
- Medtronic's cardiovascular — net sales increased by 13.8% year-over-year, from $3.34B to $3.8B.
- What is the long-term trend for Medtronic's cardiovascular — net sales?
- Over 4 years (2022 to 2026), Medtronic's cardiovascular — net sales has grown at a 5.3% compound annual growth rate (CAGR), from $11.37B to $13.98B.
- What does cardiovascular — net sales mean?
- This represents the total revenue generated from the sale of cardiovascular products, net of returns, discounts, and allowances. It is the primary indicator of the segment's market demand and commercial success. Growth in this metric is a key driver of overall company performance.
Ask your AI about Medtronic's cardiovascular — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude